Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors

Levothyroxine tablet has been used for improving serum thyroid hormones. Despite its efficacy, there has been a persistent recurrence. We aimed to evaluate the efficacy of levothyroxine regimen (administered as sodium tablets or liquid) therapy, including the regime in combination with other thyrox...

Full description

Bibliographic Details
Main Authors: Dingji Hao, Linxiao Tian, Haoting He, Congru Zhu, Lili Guo, Keao Zhang, Jie Zhang
Format: Article
Language:English
Published: PAGEPress Publications 2023-09-01
Series:European Journal of Translational Myology
Subjects:
Online Access:https://www.pagepressjournals.org/index.php/bam/article/view/11582
_version_ 1797692218044055552
author Dingji Hao
Linxiao Tian
Haoting He
Congru Zhu
Lili Guo
Keao Zhang
Jie Zhang
author_facet Dingji Hao
Linxiao Tian
Haoting He
Congru Zhu
Lili Guo
Keao Zhang
Jie Zhang
author_sort Dingji Hao
collection DOAJ
description Levothyroxine tablet has been used for improving serum thyroid hormones. Despite its efficacy, there has been a persistent recurrence. We aimed to evaluate the efficacy of levothyroxine regimen (administered as sodium tablets or liquid) therapy, including the regime in combination with other thyroxine hormones, to determine its effectiveness and safety regarding thyroid tumor patient outcomes. An electronic search of the online databases (PubMed, EMBASE, and Web of Science) was performed in duplicate independently by two authors (SSK and LPY) to identify any potential studies published in the English language from January 2002 to October 2022. The records were retrieved using keywords and MeSH terms. The Cochrane risk of bias tool in the Review Manager (RevMan software version 5.4.) was used to evaluate the risk of bias in the included studies.  A total of 18 quality studies were reported on levothyroxine tablets. Results showed that liquid levothyroxine was more efficient than tablet levothyroxine. Further results showed that levothyroxine in combination with L-T3 or I-131 was more effective than L-T4 tablet monotherapy for improving thyroid cancer hormones. Levothyroxine tablet monotherapy is less efficient than liquid levothyroxine and/or levothyroxine combined therapy. This research recommends future research using larger randomized controlled studies.
first_indexed 2024-03-12T02:24:27Z
format Article
id doaj.art-ceb954d1752043dd93653d8013b7dc8e
institution Directory Open Access Journal
issn 2037-7452
2037-7460
language English
last_indexed 2024-03-12T02:24:27Z
publishDate 2023-09-01
publisher PAGEPress Publications
record_format Article
series European Journal of Translational Myology
spelling doaj.art-ceb954d1752043dd93653d8013b7dc8e2023-09-05T22:57:34ZengPAGEPress PublicationsEuropean Journal of Translational Myology2037-74522037-74602023-09-0110.4081/ejtm.2023.11582Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumorsDingji Hao0Linxiao Tian1Haoting He2Congru Zhu3Lili Guo4Keao Zhang5Jie Zhang6Department of Oncology, Tonglu County Hospital of Traditional Chinese Medicine, Tonglu, ZhejiangDepartment of Oncology, Tonglu County Hospital of Traditional Chinese Medicine, Tonglu, ZhejiangDepartment of Oncology, Tonglu County Hospital of Traditional Chinese Medicine, Tonglu, ZhejiangDepartment of Oncology, Tonglu County Hospital of Traditional Chinese Medicine, Tonglu, ZhejiangDepartment of Oncology, Tonglu County Hospital of Traditional Chinese Medicine, Tonglu, ZhejiangDepartment of Oncology, Tonglu County Hospital of Traditional Chinese Medicine, Tonglu, ZhejiangDepartment of Oncology, Tonglu County Hospital of Traditional Chinese Medicine, Tonglu, Zhejiang Levothyroxine tablet has been used for improving serum thyroid hormones. Despite its efficacy, there has been a persistent recurrence. We aimed to evaluate the efficacy of levothyroxine regimen (administered as sodium tablets or liquid) therapy, including the regime in combination with other thyroxine hormones, to determine its effectiveness and safety regarding thyroid tumor patient outcomes. An electronic search of the online databases (PubMed, EMBASE, and Web of Science) was performed in duplicate independently by two authors (SSK and LPY) to identify any potential studies published in the English language from January 2002 to October 2022. The records were retrieved using keywords and MeSH terms. The Cochrane risk of bias tool in the Review Manager (RevMan software version 5.4.) was used to evaluate the risk of bias in the included studies.  A total of 18 quality studies were reported on levothyroxine tablets. Results showed that liquid levothyroxine was more efficient than tablet levothyroxine. Further results showed that levothyroxine in combination with L-T3 or I-131 was more effective than L-T4 tablet monotherapy for improving thyroid cancer hormones. Levothyroxine tablet monotherapy is less efficient than liquid levothyroxine and/or levothyroxine combined therapy. This research recommends future research using larger randomized controlled studies. https://www.pagepressjournals.org/index.php/bam/article/view/11582Levothyroxinelevothyroxine liquidiodine (I-131)levo-thyronine (L-T4)thyroxine serum hormonethyroid cancer
spellingShingle Dingji Hao
Linxiao Tian
Haoting He
Congru Zhu
Lili Guo
Keao Zhang
Jie Zhang
Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors
European Journal of Translational Myology
Levothyroxine
levothyroxine liquid
iodine (I-131)
levo-thyronine (L-T4)
thyroxine serum hormone
thyroid cancer
title Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors
title_full Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors
title_fullStr Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors
title_full_unstemmed Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors
title_short Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors
title_sort efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors
topic Levothyroxine
levothyroxine liquid
iodine (I-131)
levo-thyronine (L-T4)
thyroxine serum hormone
thyroid cancer
url https://www.pagepressjournals.org/index.php/bam/article/view/11582
work_keys_str_mv AT dingjihao efficacyandsafetyofpostoperativelevothyroxinesodiumtabletsforimprovingserumthyroidhormonelevelsandtumormarkerlevelsinpatientswiththyroidtumors
AT linxiaotian efficacyandsafetyofpostoperativelevothyroxinesodiumtabletsforimprovingserumthyroidhormonelevelsandtumormarkerlevelsinpatientswiththyroidtumors
AT haotinghe efficacyandsafetyofpostoperativelevothyroxinesodiumtabletsforimprovingserumthyroidhormonelevelsandtumormarkerlevelsinpatientswiththyroidtumors
AT congruzhu efficacyandsafetyofpostoperativelevothyroxinesodiumtabletsforimprovingserumthyroidhormonelevelsandtumormarkerlevelsinpatientswiththyroidtumors
AT liliguo efficacyandsafetyofpostoperativelevothyroxinesodiumtabletsforimprovingserumthyroidhormonelevelsandtumormarkerlevelsinpatientswiththyroidtumors
AT keaozhang efficacyandsafetyofpostoperativelevothyroxinesodiumtabletsforimprovingserumthyroidhormonelevelsandtumormarkerlevelsinpatientswiththyroidtumors
AT jiezhang efficacyandsafetyofpostoperativelevothyroxinesodiumtabletsforimprovingserumthyroidhormonelevelsandtumormarkerlevelsinpatientswiththyroidtumors